Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2018 (2018), Article ID 9079527, 11 pages
https://doi.org/10.1155/2018/9079527
Research Article

Tabetri™ (Tabebuia avellanedae Ethanol Extract) Ameliorates Atopic Dermatitis Symptoms in Mice

1Department of Genetic Engineering, Sungkyunkwan University, Suwon 16419, Republic of Korea
2Department of Pharmaceutical Engineering, Cheongju University, Cheongju 28503, Republic of Korea
3College of Veterinary Medicine, Chonbuk National University, Iksan 54596, Republic of Korea
4R&I Planning Department, Nutribiotech Co. Ltd., Seoul 06132, Republic of Korea
5Department of Information Statistics, Kangwon National University, Chuncheon 24341, Republic of Korea
6Department of Pharmacy, Sunchon National University, Suncheon 57922, Republic of Korea

Correspondence should be addressed to Young-Jin Son; rk.ca.nohcnus@ynos, Jong-Hoon Kim; rk.ca.unbj@1mikhj, and Jae Youl Cho; ude.ukks@ohceaj

Received 1 October 2017; Accepted 3 January 2018; Published 15 March 2018

Academic Editor: Shin-ichi Yokota

Copyright © 2018 Jae Gwang Park et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Y. Leung, M. Boguniewicz, M. D. Howell, I. Nomura, and Q. A. Hamid, “New insights into atopic dermatitis,” The Journal of Clinical Investigation, vol. 113, no. 5, pp. 651–657, 2004. View at Publisher · View at Google Scholar
  2. M. Boguniewicz and D. Y. Leung, “Recent insights into atopic dermatitis and implications for management of infectious complications,” The Journal of Allergy and Clinical Immunology, vol. 125, no. 1, pp. 4–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J. I. Silverberg, D. B. Nelson, and G. Yosipovitch, “Addressing treatment challenges in atopic dermatitis with novel topical therapies,” Journal of Dermatological Treatment, vol. 27, no. 6, pp. 568–576, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Hong, J. Buddenkotte, T. G. Berger, and M. Steinhoff, “Management of itch in atopic dermatitis,” Seminars in Cutaneous Medicine and Surgery, vol. 30, no. 2, pp. 71–86, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Yosipovitch and A. D. Papoiu, “What causes itch in atopic dermatitis?” Current Allergy and Asthma Reports, vol. 8, no. 4, pp. 306–311, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. E. L. Simpson, L. F. Eichenfield, C. N. Ellis, A. J. Mancini, and A. S. Paller, “Current issues in atopic comorbidities and preventing the atopic march,” Seminars in Cutaneous Medicine and Surgery, vol. 31, no. 3, pp. S6–S9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. J. I. Silverberg and E. L. Simpson, “Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization,” Pediatric Allergy and Immunology, vol. 24, no. 5, pp. 476–486, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Williams, A. Stewart, E. von Mutius, W. Cookson, and H. Ross Anderson, “Is eczema really on the increase worldwide?” The Journal of Allergy and Clinical Immunology, vol. 121, no. 4, pp. 947–954.e15, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. A. Odhiambo, H. C. Williams, T. O. Clayton, C. F. Robertson, M. I. Asher, and ISAAC Phase Three Study Group, “Global variations in prevalence of eczema symptoms in children from ISAAC phase three,” The Journal of Allergy and Clinical Immunology, vol. 124, no. 6, pp. 1251–1258.e23, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. E. L. M. M. Simpson, A. D. M. Irvine, L. F. M. Eichenfield, and S. F. M. Friedlander, “Update on epidemiology, diagnosis, and disease course of atopic dermatitis,” Seminars in Cutaneous Medicine and Surgery, vol. 35, no. 5S, pp. S84–S88, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Udkoff, A. Waldman, J. Ahluwalia, J. Borok, and L. F. Eichenfield, “Current and emerging topical therapies for atopic dermatitis,” Clinics in Dermatology, vol. 35, no. 4, pp. 375–382, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. C. A. Janeway Jr. and R. Medzhitov, “Innate immune recognition,” Annual Review of Immunology, vol. 20, no. 1, pp. 197–216, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. S. Yi, “Folate receptor-targeted diagnostics and therapeutics for inflammatory diseases,” Immune Network, vol. 16, no. 6, pp. 337–343, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. J. H. Kim, B. C. Yoo, W. S. Yang, E. Kim, S. Hong, and J. Y. Cho, “The role of protein arginine methyltransferases in inflammatory responses,” Mediators in Inflammation, vol. 2016, article 4028353, 11 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Kaur, M. Singh, and O. Silakari, “Inhibitors of switch kinase ‘spleen tyrosine kinase’ in inflammation and immune-mediated disorders: a review,” European Journal of Medicinal Chemistry, vol. 67, pp. 434–446, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. K. S. Baek, Y. S. Yi, Y. J. Son et al., “In vitro and in vivo anti-inflammatory activities of Korean red ginseng-derived components,” Journal of Ginseng Research, vol. 40, no. 4, pp. 437–444, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. S. Yi, Y. J. Son, C. Ryou, G. H. Sung, J. H. Kim, and J. Y. Cho, “Functional roles of Syk in macrophage-mediated inflammatory responses,” Mediators in Inflammation, vol. 2014, article 270302, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Yang, S. C. Kim, T. Yu et al., “Functional roles of p38 mitogen-activated protein kinase in macrophage-mediated inflammatory responses,” Mediators of Inflammation, vol. 2014, Article ID 352371, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Yu, Y. S. Yi, Y. Yang, J. Oh, D. Jeong, and J. Y. Cho, “The pivotal role of TBK1 in inflammatory responses mediated by macrophages,” Mediators of Inflammation, vol. 2012, Article ID 979105, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. S. E. Byeon, Y. S. Yi, J. Oh, B. C. Yoo, S. Hong, and J. Y. Cho, “The role of Src kinase in macrophage-mediated inflammatory responses,” Mediators of Inflammation, vol. 2012, Article ID 512926, 18 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Akdis, A. Trautmann, S. Klunker et al., “T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells,” The FASEB Journal, vol. 17, no. 9, pp. 1026–1035, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Forbes, N. van Panhuys, B. Min, and G. Le Gros, “Differential requirements for IL-4/STAT6 signalling in CD4 T-cell fate determination and Th2-immune effector responses,” Immunology & Cell Biology, vol. 88, no. 3, pp. 240–243, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Maeda and Y. Yanagihara, “Inflammatory cytokines (IL-4, IL-5 and IL-13),” Nihon Rinsho Japanese Journal of Clinical Medicine, vol. 59, no. 10, pp. 1894–1899, 2001. View at Google Scholar
  24. M. Wegmann, “Th2 cells as targets for therapeutic intervention in allergic bronchial asthma,” Expert Review of Molecular Diagnostics, vol. 9, no. 1, pp. 85–100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Grewe, W. Czech, A. Morita et al., “Human eosinophils produce biologically active IL-12: implications for control of T cell responses,” Journal of Immunology, vol. 161, no. 1, pp. 415–420, 1998. View at Google Scholar
  26. G. E. Ji, “Probiotics in primary prevention of atopic dermatitis,” Forum of Nutrition, vol. 61, pp. 117–128, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. C. G. Casinovi, G. B. Marini Bettolo, D. A. Limaog, M. E. Daliamaia, and I. L. d’ Albuquerque, “Quinones isolated from the wood of Tabebuia avellanedae Lor. Ex Griseb,” Rendiconti-Istituto Superiore di Sanità, vol. 26, pp. 5–10, 1963. View at Google Scholar
  28. C. F. de Santana, O. de Lima, I. L. d’ Albuquerque, A. L. Lacerda, and D. G. Martins, “Antitumoral and toxicological properties of extracts of bark and various wood components of Pau d’arco (Tabebuia avellanedae),” Revista do Instituto de Antibióticos, Universidade Federal de Pernambuco, vol. 8, no. 1, pp. 89–94, 1968. View at Google Scholar
  29. H. J. Woo and Y. H. Choi, “Growth inhibition of A549 human lung carcinoma cells by β-lapachone through induction of apoptosis and inhibition of telomerase activity,” International Journal of Oncology, vol. 26, no. 4, pp. 1017–1023, 2005. View at Publisher · View at Google Scholar
  30. B. T. Choi, J. Cheong, and Y. H. Choi, “Beta-Lapachone-induced apoptosis is associated with activation of caspase-3 and inactivation of NF-kappaB in human colon cancer HCT-116 cells,” Anti-Cancer Drugs, vol. 14, no. 10, pp. 845–850, 2003. View at Publisher · View at Google Scholar
  31. E. M. Pereira, B. Machado Tde, I. C. Leal et al., “Tabebuia avellanedae naphthoquinones: Activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivo dermal irritability analysis,” Annals of Clinical Microbiology and Antimicrobials, vol. 5, no. 1, p. 5, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. S. O. Kim, J. I. Kwon, Y. K. Jeong, G. Y. Kim, N. D. Kim, and Y. H. Choi, “Induction of Egr-1 is associated with anti-metastatic and anti-invasive ability of β-lapachone in human hepatocarcinoma cells,” Bioscience, Biotechnology, and Biochemistry, vol. 71, no. 9, pp. 2169–2176, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. H. N. Kung, C. L. Chien, G. Y. Chau, M. J. Don, K. S. Lu, and Y. P. Chau, “Involvement of NO/cGMP signaling in the apoptotic and anti-angiogenic effects of β-lapachone on endothelial cells in vitro,” Journal of Cellular Physiology, vol. 211, no. 2, pp. 522–532, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Xu, G. Wagoner, J. C. Douglas, and P. D. Drew, “β-Lapachone ameliorization of experimental autoimmune encephalomyelitis,” Journal of Neuroimmunology, vol. 254, no. 1-2, pp. 46–54, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Zhang, I. Hasegawa, and T. Ohta, “Anti-inflammatory cyclopentene derivatives from the inner bark of Tabebuia avellanedae,” Fitoterapia, vol. 109, pp. 217–223, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. J. G. Park, Y. J. Son, M. Y. Kim, and J. Y. Cho, “Syk and IRAK1 contribute to immunopharmacological activities of anthraquinone-2-carboxlic acid,” Molecules, vol. 21, no. 6, p. 809, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. T. B. Machado, A. V. Pinto, M. C. Pinto et al., “In vitro activity of Brazilian medicinal plants, naturally occurring naphthoquinones and their analogues, against methicillin-resistant Staphylococcus aureus,” International Journal of Antimicrobial Agents, vol. 21, no. 3, pp. 279–284, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Awale, T. Kawakami, Y. Tezuka, J. Y. Ueda, K. Tanaka, and S. Kadota, “Nitric oxide (NO) production inhibitory constituents of Tabebuia avellanedae from Brazil,” Chemical and Pharmaceutical Bulletin, vol. 53, no. 6, pp. 710–713, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Bohler, J. Nolting, P. Gurragchaa et al., “Tabebuia avellanedae extracts inhibit IL-2-independent T-lymphocyte activation and proliferation,” Transplant Immunology, vol. 18, no. 4, pp. 319–323, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. E. J. Lee, H. M. Ko, Y. H. Jeong, E. M. Park, and H. S. Kim, “β-Lapachone suppresses neuroinflammation by modulating the expression of cytokines and matrix metalloproteinases in activated microglia,” Journal of Neuroinflammation, vol. 12, no. 1, p. 133, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. J. H. Choi, Y. S. Song, H. J. Lee, G. C. Kim, and J. W. Hong, “The topical application of low-temperature argon plasma enhances the anti-inflammatory effect of Jaun-ointment on DNCB-induced NC/Nga mice,” BMC Complementary & Alternative Medicine, vol. 17, no. 1, p. 340, 2017. View at Publisher · View at Google Scholar · View at Scopus
  42. K. H. Lu, C. Y. Weng, W. C. Chen, and L. Y. Sheen, “Ginseng essence, a medicinal and edible herbal formulation, ameliorates carbon tetrachloride-induced oxidative stress and liver injury in rats,” Journal of Ginseng Research, vol. 41, no. 3, pp. 316–325, 2017. View at Publisher · View at Google Scholar · View at Scopus
  43. J. G. Park, W. S. Kang, K. T. Park, A. Aravinthan, J. H. Kim, and J. Y. Cho, “Anticancer effect of joboksansam, Korean wild ginseng germinated from bird feces,” Journal of Ginseng Research, vol. 40, no. 3, pp. 304–308, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. J. G. Park, Y. J. Son, A. Aravinthan, J. H. Kim, and J. Y. Cho, “Korean red ginseng water extract arrests growth of xenografted lymphoma cells,” Journal of Ginseng Research, vol. 40, no. 4, pp. 431–436, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. M. J. Hossen, Y. D. Hong, K. S. Baek et al., “In vitro antioxidative and anti-inflammatory effects of the compound K-rich fraction BIOGF1K, prepared from Panax ginseng,” Journal of Ginseng Research, vol. 41, no. 1, pp. 43–51, 2017. View at Publisher · View at Google Scholar · View at Scopus
  46. S. E. Byeon, J. Y. Chung, Y. G. Lee, B. H. Kim, K. H. Kim, and J. Y. Cho, “In vitro and in vivo anti-inflammatory effects of taheebo, a water extract from the inner bark of Tabebuia avellanedae,” Journal of Ethnopharmacology, vol. 119, no. 1, pp. 145–152, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. M. H. Lee, H. M. Choi, D. H. Hahm et al., “Analgesic and anti-inflammatory effects in animal models of an ethanolic extract of taheebo, the inner bark of Tabebuia avellanedae,” Molecular Medicine Reports, vol. 6, no. 4, pp. 791–796, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. K. E. Hyung, S. J. Kim, Y. W. Jang et al., “Therapeutic effects of orally administered CJLP55 for atopic dermatitis via the regulation of immune response,” The Korean Journal of Physiology & Pharmacology, vol. 21, no. 3, pp. 335–343, 2017. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Kapoor, C. Menon, O. Hoffstad, W. Bilker, P. Leclerc, and D. J. Margolis, “The prevalence of atopic triad in children with physician-confirmed atopic dermatitis,” Journal of the American Academy of Dermatology, vol. 58, no. 1, pp. 68–73, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Y. Leung and T. Bieber, “Atopic dermatitis,” The Lancet, vol. 361, no. 9352, pp. 151–160, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. J. M. Spergel, “From atopic dermatitis to asthma: the atopic march,” Annals of Allergy, Asthma & Immunology, vol. 105, no. 2, pp. 99–106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Kabashima, “New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity,” Journal of Dermatological Science, vol. 70, no. 1, pp. 3–11, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. J. M. Dwyer and C. Johnson, “The use of concanavalin A to study the immunoregulation of human T cells,” Clinical & Experimental Immunology, vol. 46, no. 2, pp. 237–249, 1981. View at Google Scholar
  54. S. Phipps, C. E. Lam, S. Mahalingam et al., “Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus,” Blood, vol. 110, no. 5, pp. 1578–1586, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. A. M. Kvarnhammar and L. O. Cardell, “Pattern-recognition receptors in human eosinophils,” Immunology, vol. 136, no. 1, pp. 11–20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. W. J. Kim, H. S. Cha, M. H. Lee, S. Y. Kim, S. H. Kim, and T. J. Kim, “Effects of Cymbidium root ethanol extract on atopic dermatitis,” Evidence-based Complementary and Alternative Medicine, vol. 2016, Article ID 5362475, 10 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  57. S. T. Nam, Y. H. Park, H. W. Kim et al., “Suppression of IgE-mediated mast cell activation and mouse anaphylaxis via inhibition of Syk activation by 8-formyl-7-hydroxy-4-methylcoumarin, 4μ8C,” Toxicology and Applied Pharmacology, vol. 332, pp. 25–31, 2017. View at Publisher · View at Google Scholar · View at Scopus
  58. J. G. Park, S. C. Kim, Y. H. Kim et al., “Anti-inflammatory and antinociceptive activities of anthraquinone-2-carboxylic acid,” Mediators of Inflammation, vol. 2016, Article ID 1903849, 12 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus